Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Galectin Therapeutics Inc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- 0 vs. Q1 2026
- Shares held
- 15.6M
- +1.69M (+12.1%) vs. Q1 2026
- Total value
- $72.2M
- +$33.4M (+86.3%) vs. Q1 2026
- New holders
- 20
- 32 more added
- Sold out
- 20
- 23 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GALT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 98 | $72.2M |
| Q1 2026 | 99 | $38.8M |
| Q4 2025 | 98 | $48.1M |
| Q3 2025 | 84 | $43.9M |
| Q2 2025 | 86 | $22.2M |
| Q1 2025 | 93 | $12.2M |
| Q4 2024 | 94 | $13.0M |
| Q3 2024 | 79 | $26.8M |
| Q2 2024 | 73 | $21.6M |
| Q1 2024 | 59 | $18.2M |
| Q4 2023 | 66 | $12.0M |
| Q3 2023 | 60 | $17.4M |
| Q2 2023 | 60 | $10.5M |
| Q1 2023 | 60 | $15.0M |
| Q4 2022 | 61 | $8.04M |
| Q3 2022 | 59 | $11.3M |
| Q2 2022 | 60 | $9.25M |
| Q1 2022 | 60 | $12.0M |
| Q4 2021 | 55 | $15.2M |
| Q3 2021 | 70 | $28.2M |
| Q2 2021 | 75 | $25.3M |
| Q1 2021 | 75 | $22.7M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Galectin Therapeutics Inc; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −162,484−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −126,439−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −74,728−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −51,058−100.0% | Sold out |
| Wiley Bros.-Aintree Capital, LLC | 0 | $0 | 0.00% | −41,000−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −35,585−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −24,100−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −22,500−100.0% | Sold out |
| Nine Masts Capital Ltd | 0 | $0 | 0.00% | −19,324−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,739−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −17,089−100.0% | Sold out |
| Colony Group, LLC | 0 | $0 | 0.00% | −13,897−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −12,188−100.0% | Sold out |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −10,113−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −2,980−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Hamrick Investment Counsel, llc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |